Skip to main content

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Blueprint Medicines Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Blueprint Medicines Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Blueprint Medicines Corp
NameTitleLast reported holdingLast filingFilings, past year
Borisy AlexisDirector0Jul 21, 20250
Seely LynnDirector0Jul 21, 20250
Beckman DaniellaDirector0Jul 21, 20250
Goldberg Mark AlanDirector0Jul 21, 20250
Coats LonnelDirector0Jul 21, 20250
Albers Jeffrey W.Director0Jul 21, 20250
Landsittel MichaelChief Financial Officer0Jul 21, 20250
Haviland KateChief Executive Officer0Jul 21, 20250
McCain Tracey LEVP & Chief Legal Officer0Jul 21, 20250
Dable Habib JDirector0Jul 21, 20250
Rossi ChristinaChief Operating Officer0Jul 21, 20250
Hurley ArielPrincipal Accounting Officer0Jul 21, 20250
Durso-Bumpus DebraChief People Officer0Jul 21, 20250
Namouni FouadPRESIDENT, R & D0Jul 21, 20250
Hewes L. BeckerChief Medical Officer0Jul 21, 20250
Lee PhilinaChief Commercial Officer0Jul 21, 20250
Carter Percy H.Chief Scientific Officer0Jul 21, 20250
Tsai JohnDirector0Jul 21, 20250
Lydon NicholasDirector58,026Jun 14, 20240
Murray Christopher K.CHIEF TECHNICAL OPERATIONS33,853Mar 11, 20240
Demetri GeorgeDirector8,412Jun 30, 20220
Tango Therapeutics, Inc.Director3,400Dec 10, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 19, 2021 (view filing)Aug 172 daysHurley ArielPrincipal Accounting OfficerSSale−1.35K$91.93−$124.1K−11.8%10.1K after
Aug 23, 2021 (view filing)Aug 194 daysAlbers Jeffrey W.CEO and PresidentSSale−25.0K$92.68−$2.32M−12.7%172.4K after2 lots
Sep 15, 2021 (view filing)Sep 132 daysHaviland KateChief Operating OfficerSSale−1.00K$99.94−$99.9K−1.8%53.9K after5 lots
Sep 15, 2021 (view filing)Sep 132 daysHurley ArielPrincipal Accounting OfficerSSale−600$100.00−$60.0K−5.6%10.1K after
Sep 17, 2021 (view filing)Jun 2107 daysLateHewes L. BeckerChief Medical OfficerSSale−1.29K$89.03−$115.0K−4.2%29.3K after
Sep 17, 2021 (view filing)Sep 152 daysHewes L. BeckerChief Medical OfficerSSale−11.8K$101.17−$1.20M−31.1%26.2K after4 lots
Sep 27, 2021 (view filing)Sep 234 daysDurso-Bumpus DebraChief People OfficerSSale−848$110.01−$93.3K−2.7%30.9K after
Sep 27, 2021 (view filing)Sep 234 daysMcCain Tracey LEVP and Chief Legal OfficerSSale−25.0K$108.85−$2.72M−42.9%33.3K after3 lots
Sep 27, 2021 (view filing)Sep 234 daysHurley ArielPrincipal Accounting OfficerSSale−600$110.00−$66.0K−5.6%10.1K after
Oct 7, 2021 (view filing)Oct 52 daysNamouni FouadPresident, R & DSSale−3.24K$98.18−$318.2K−7.1%42.3K after
Oct 19, 2021 (view filing)Oct 154 daysHewes L. BeckerChief Medical OfficerSSale−729$102.66−$74.8K−2.7%26.2K after
Nov 3, 2021 (view filing)Nov 12 daysAlbers Jeffrey W.CEO and PresidentSSale−5.00K$115.16−$575.8K−2.6%188.4K after
Nov 3, 2021 (view filing)Nov 12 daysDurso-Bumpus DebraChief People OfficerSSale−5.18K$113.03−$585.2K−14.4%30.9K after3 lots
Nov 5, 2021 (view filing)Nov 32 daysMcCain Tracey LEVP and Chief Legal OfficerSSale−5.00K$110.56−$552.8K−13.1%33.3K after2 lots
Nov 17, 2021 (view filing)Nov 152 daysHewes L. BeckerChief Medical OfficerSSale−729$115.49−$84.2K−2.7%26.2K after
Nov 17, 2021 (view filing)Nov 152 daysAlbers Jeffrey W.CEO and PresidentSSale−30.0K$114.50−$3.44M−13.7%188.4K after4 lots
Nov 18, 2021 (view filing)Nov 162 daysHurley ArielPrincipal Accounting OfficerSSale−1.95K$114.28−$222.8K−16.2%10.1K after
Dec 9, 2021 (view filing)Dec 72 daysMcCain Tracey LEVP and Chief Legal OfficerSSale−5.00K$97.30−$486.5K−13.0%33.4K after3 lots
Dec 15, 2021 (view filing)Dec 132 daysHaviland KateChief Operating OfficerSSale−1.00K$98.30−$98.3K−1.8%53.9K after4 lots
Dec 17, 2021 (view filing)Dec 152 daysHewes L. BeckerChief Medical OfficerSSale−729$100.00−$72.9K−2.7%26.2K after
Mar 7, 2022 (view filing)Mar 34 daysGoldberg Mark AlanDirectorPPurchase+5.00K$59.98+$299.9K+86.0%10.8K after
Mar 8, 2022 (view filing)Mar 3-75 daysLateDurso-Bumpus DebraCHIEF PEOPLE OFFICERSSale−2.54K$58.59−$148.7K−5.9%40.8K after2 lots
Mar 8, 2022 (view filing)Mar 3-75 daysLateHaviland KateCHIEF OPERATING OFFICERSSale−2.77K$58.72−$162.5K−2.9%91.2K after2 lots
Mar 8, 2022 (view filing)Mar 71 dayHewes L. BeckerCHIEF MEDICAL OFFICERSSale−1.05K$56.19−$58.8K−3.0%33.9K after
Mar 8, 2022 (view filing)Mar 3-75 daysLateLandsittel MichaelCHIEF FINANCIAL OFFICERSSale−2.38K$58.47−$138.9K−5.7%39.0K after2 lots
Mar 8, 2022 (view filing)Mar 3-75 daysLateMcCain Tracey LEVP AND CHIEF LEGAL OFFICERSSale−2.71K$58.70−$159.3K−5.9%43.2K after2 lots
Mar 8, 2022 (view filing)Mar 3-75 daysLateMurray Christopher K.SVP, TECHNICAL OPERATIONSSSale−1.57K$58.96−$92.5K−6.2%23.8K after2 lots
Mar 8, 2022 (view filing)Mar 71 dayNamouni FouadPRESIDENT, R & DSSale−1.05K$56.19−$58.8K−1.8%56.3K after
Mar 8, 2022 (view filing)Mar 3-75 daysLateRossi ChristinaCHIEF COMMERCIAL OFFICERSSale−2.24K$58.37−$131.0K−4.8%44.5K after2 lots
Mar 8, 2022 (view filing)Mar 3-75 daysLateAlbers Jeffrey W.CEO AND PRESIDENTSSale−32.7K$57.90−$1.89M−15.1%183.2K after6 lots
Mar 8, 2022 (view filing)Mar 3-75 daysLateHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−1.02K$59.24−$60.3K−7.8%12.0K after2 lots
Mar 14, 2022 (view filing)Mar 104 daysHurley ArielPRINCIPAL ACCOUNTING OFFICERSSale−2.34K$57.15−$133.7K−19.6%9.62K after
Mar 18, 2022 (view filing)Mar 162 daysHewes L. BeckerCHIEF MEDICAL OFFICERSSale−2.22K$60.00−$133.1K−6.5%31.7K after
Mar 23, 2022 (view filing)Nov 3, 2021140 daysLateRossi ChristinaCHIEF COMMERCIAL OFFICERSSale−511$110.85−$56.6K−1.1%44.0K after
Apr 8, 2022 (view filing)Apr 62 daysAlbers Jeffrey W.CEO AND PRESIDENTSSale−5.00K$70.11−$350.6K−2.7%183.2K after
May 18, 2022 (view filing)May 162 daysAlbers Jeffrey W.DirectorSSale−20.0K$55.89−$1.12M−9.8%183.2K after3 lots
Jun 8, 2022 (view filing)Jun 6-72 daysHewes L. BeckerCHIEF MEDICAL OFFICERSSale−4.38K$59.93−$262.2K−13.8%27.3K after2 lots
Jun 8, 2022 (view filing)Jun 62 daysCarter Percy H.CHIEF SCIENTIFIC OFFICERSSale−1.91K$59.76−$114.0K−6.2%28.7K after
Jun 30, 2022 (view filing)Jul 13, 2021352 daysLateDemetri GeorgeDirectorPPurchase+10$82.66+$826.6+0.2%5.82K after
Jun 30, 2022 (view filing)Mar 17105 daysLateDemetri GeorgeDirectorSSale−10$58.56−$585.6−0.2%5.81K after
Aug 8, 2022 (view filing)Aug 4-54 daysMurray Christopher K.SVP, TECHNICAL OPERATIONSSSale−5.00K$62.72−$313.6K−21.0%18.8K after2 lots
Aug 10, 2022 (view filing)Aug 82 daysAlbers Jeffrey W.DirectorSSale−10.0K$70.07−$700.7K−5.2%183.2K after
Aug 18, 2022 (view filing)Aug 162 daysAlbers Jeffrey W.DirectorSSale−20.0K$68.41−$1.37M−9.8%183.2K after3 lots
Aug 23, 2022 (view filing)Aug 19-224 daysAlbers Jeffrey W.DirectorSSale−10.0K$70.45−$704.5K−5.2%183.2K after3 lots
Aug 26, 2022 (view filing)Aug 242 daysDurso-Bumpus DebraCHIEF PEOPLE OFFICERSSale−5.00K$75.11−$375.6K−10.9%40.8K after
Oct 5, 2022 (view filing)Oct 41 dayNamouni FouadPRESIDENT, R & DSSale−3.48K$67.30−$234.0K−6.2%52.8K after
Nov 7, 2022 (view filing)Nov 34 daysHaviland KateCHIEF EXECUTIVE OFFICERPPurchase+1.10K$43.98+$48.4K+1.2%92.3K after
Nov 7, 2022 (view filing)Nov 34 daysRossi ChristinaCHIEF OPERATING OFFICERSSale−533$45.24−$24.1K−1.2%43.4K after
Dec 7, 2022 (view filing)Dec 52 daysAlbers Jeffrey W.DirectorSSale−20.0K$50.09−$1.00M−9.8%183.2K after
Mar 8, 2023 (view filing)Mar 62 daysHaviland KateCHIEF EXECUTIVE OFFICERSSale−6.64K$45.69−$303.4K−5.0%125.6K after2 lots